2013
DOI: 10.1007/s12603-012-0420-6
|View full text |Cite
|
Sign up to set email alerts
|

Effect of long-term treatment with galantamine on weight of patients with Alzheimer's dementia

Abstract: Weight loss in AD patients should not be attributed to long-term treatment with galantamine. This is in accordance with the French guideline. If AD patients are losing weight, other causes, including insufficient care, should be investigated.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
3
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 16 publications
(4 citation statements)
references
References 22 publications
1
3
0
Order By: Relevance
“…As recently shown by applying the MNA to an Iranian rural population, the risk of severe depression in patients with malnutrition was 15.5 times higher than in non-depressed persons [23]. In agreement with the observation of Droogsma et al [24] who reported that Alzheimer patients at risk of malnutrition are more impaired in basic and complex daily functioning than those well-nourished, our data confirm the higher rate of complications (i.e. pressure sores, respiratory infections, …) in malnourished patients with dementia.…”
Section: Age (Years)supporting
confidence: 89%
“…As recently shown by applying the MNA to an Iranian rural population, the risk of severe depression in patients with malnutrition was 15.5 times higher than in non-depressed persons [23]. In agreement with the observation of Droogsma et al [24] who reported that Alzheimer patients at risk of malnutrition are more impaired in basic and complex daily functioning than those well-nourished, our data confirm the higher rate of complications (i.e. pressure sores, respiratory infections, …) in malnourished patients with dementia.…”
Section: Age (Years)supporting
confidence: 89%
“…Since the market approval of AChEIs, the association between AChEI treatment and BW loss has been investigated. One group observed a 23% risk of BW loss in individuals with dementia taking AChEIs [109], while others concluded AChEI treatment is protective against BW loss seen in dementia [110] (however, the latter study lacked a control group). Crucially, in a meta-analysis of 25 clinical AChEI trials and others, an increased risk of BW loss was observed for every AChEI [111, 112].…”
Section: Pharmacotherapies For Dementia: Effects On Body Weight Andmentioning
confidence: 99%
“…The long-term effects of the ChEI galantamine on weight of community-dwelling AD patients were investigated. The results of this study showed that long-term treatment with galantamine had no effect on the weight of AD patients [7]. Weight loss in AD patients should therefore not be attributed to long-term treatment with galantamine.…”
Section: Epidemiology Of Weight Loss and Undernutritionmentioning
confidence: 59%
“…In the study on the prevalence of undernutrition and its relation to various factors in community-dwelling elderly with newly diagnosed AD, it was shown that the degree of impairment in daily functioning is independently related to nutritional status [8]. In addition, it was shown that community-dwelling AD patients without an informal caregiver or partner had a lower average weight compared to patients with an informal caregiver or partner [7]. Therefore, if AD patients develop a poor nutritional status, it is important to establish whether care is sufficient and if necessary that appropriate care is arranged, for example starting meals at home services or supervision of meal intake.…”
Section: Interventions Targeting the Underlying Proposed Causes And Rmentioning
confidence: 99%